Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

NCT07302802 · clinicaltrials.gov ↗

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Monogenic Obesity

Interventions

DRUG: Semaglutide (administered by PDS290 pen-injector)

Sponsor

Prof. Dr. Martin Wabitsch

Collaborators

[object Object]